{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:47:51Z","timestamp":1791913671124,"version":"4.3.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:00:00Z","timestamp":1791849600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-026-01242-6","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T05:03:34Z","timestamp":1791867814000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Joint association of growth hormone and cerebral small vessel disease with antihypertensive treatment burden after stroke: an exploratory prospective study"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1973-4816","authenticated-orcid":false,"given":"Motohiro","family":"Okumura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2059-9327","authenticated-orcid":false,"given":"Takeo","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tsujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Yamashiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yui","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taku","family":"Gomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideto","family":"Kuribayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9722-1656","authenticated-orcid":false,"given":"Teppei","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Sakuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Mitsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimei","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,13]]},"reference":[{"key":"1242_CR1","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1161\/STROKEAHA.121.035851","volume":"53","author":"IJ McGurgan","year":"2022","unstructured":"McGurgan IJ, Kelly PJ, Turan TN, Rothwell PM. Long-Term secondary prevention: management of blood pressure after a transient ischemic attack or stroke. Stroke. 2022;53:1085\u2013103.","journal-title":"Stroke"},{"key":"1242_CR2","doi-asserted-by":"publisher","first-page":"e364","DOI":"10.1161\/STR.0000000000000375","volume":"52","author":"DO Kleindorfer","year":"2021","unstructured":"Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American heart association\/American stroke association. Stroke. 2021;52:e364\u2013e467.","journal-title":"Stroke"},{"key":"1242_CR3","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","volume":"53","author":"SM Greenberg","year":"2022","unstructured":"Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association. Stroke. 2022;53:e282\u2013e361.","journal-title":"Stroke"},{"key":"1242_CR4","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"G Mancia","year":"2023","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, et al. 2023 ESH guidelines for the management of arterial hypertension the task force for the management of arterial hypertension of the european society of hypertension. J Hypertens. 2023;41:1874\u20132071.","journal-title":"J Hypertens"},{"key":"1242_CR5","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1161\/HYPERTENSIONAHA.119.12907","volume":"74","author":"CG Derington","year":"2019","unstructured":"Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, et al. Association of total medication burden with intensive and standard blood pressure control and clinical outcomes: a secondary analysis of SPRINT. Hypertension. 2019;74:267\u201375.","journal-title":"Hypertension"},{"key":"1242_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.atherosclerosis.2022.09.004","volume":"359","author":"N Wettersten","year":"2022","unstructured":"Wettersten N, Mital R, Cushman M, Howard G, Judd SE, Howard VJ, et al. Growth hormone concentration and risk of all-cause and cardiovascular mortality: the REasons for geographic and racial disparities in stroke (REGARDS) study. Atherosclerosis. 2022;359:20\u201326.","journal-title":"Atherosclerosis"},{"key":"1242_CR7","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1210\/er.2008-0027","volume":"30","author":"N M\u00f8ller","year":"2009","unstructured":"M\u00f8ller N, J\u00f8rgensen JOL. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocr Rev. 2009;30:152\u201377.","journal-title":"Endocr Rev"},{"key":"1242_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","volume":"18","author":"JM Wardlaw","year":"2019","unstructured":"Wardlaw JM, Smith C, Dichgans M. Small vessel disease: mechanisms and clinical implications. Lancet Neurol. 2019;18:684\u201396.","journal-title":"Lancet Neurol"},{"key":"1242_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.034116","volume":"13","author":"T Lohman","year":"2024","unstructured":"Lohman T, Sible I, Kapoor A, Engstrom AC, Shenasa F, Alitin JPM, et al. Blood pressure variability, central autonomic network dysfunction, and cerebral small\u2010vessel disease in APOE4 carriers. J Am Heart Assoc: Cardiovasc Cerebrovasc Dis. 2024;13:e034116.","journal-title":"J Am Heart Assoc: Cardiovasc Cerebrovasc Dis"},{"key":"1242_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2023.1190869","volume":"15","author":"H Du","year":"2023","unstructured":"Du H, Xia J, Huang L, Zheng L, Gu W, Yi F. Relationship between insulin-like growth factor-1 and cerebral small vessel disease and its mechanisms: advances in the field. Front Aging Neurosci. 2023;15:1190869.","journal-title":"Front Aging Neurosci"},{"key":"1242_CR11","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11357-016-9931-0","volume":"38","author":"S Tarantini","year":"2016","unstructured":"Tarantini S, Tucsek Z, Valcarcel-Ares MN, Toth P, Gautam T, Giles CB, et al. Circulating IGF-1 deficiency exacerbates hypertension-induced microvascular rarefaction in the mouse hippocampus and retrosplenial cortex: implications for cerebromicrovascular and brain aging. AGE. 2016;38:273\u201389.","journal-title":"AGE"},{"key":"1242_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.948971","volume":"12","author":"Z Xie","year":"2022","unstructured":"Xie Z, Zhuang Y, Zhang Z, Liu J. Presence of cerebral microbleeds is associated with cognitive decline in acromegaly. Front Oncol. 2022;12:948971.","journal-title":"Front Oncol"},{"key":"1242_CR13","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1038\/s41440-025-02351-4","volume":"48","author":"M Okumura","year":"2025","unstructured":"Okumura M, Sato T, Tsujimoto Y, Yamashiro K, Watanabe Y, Matsushima S, et al. Prospective study of primary aldosteronism in acute ischemic stroke: association with small vessel disease. Hypertens Res. 2025;48:2841\u201353.","journal-title":"Hypertens Res"},{"key":"1242_CR14","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1507\/endocrj.EJ12-0110","volume":"59","author":"T Isojima","year":"2012","unstructured":"Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, Hizuka N, et al. Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J. 2012;59:771\u201380.","journal-title":"Endocr J"},{"key":"1242_CR15","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.7754\/Clin.Lab.2014.131020","volume":"60","author":"J Helden","year":"2014","unstructured":"Helden J, Hermsen D, Ahsen N, Bidlingmaier M. Performance evaluation of a fully automated immunoassay for the detection of human growth hormone on the elecsys\u00ae immunoassay system. Clin Lab. 2014;60:1641\u201351.","journal-title":"Clin Lab"},{"key":"1242_CR16","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/jp.2016.247","volume":"37","author":"SE Allen","year":"2017","unstructured":"Allen SE, Tita A, Anderson S, Biggio JR, Harper DLM. Is use of multiple antihypertensive agents to achieve blood pressure control associated with adverse pregnancy outcomes? J Perinatol. 2017;37:340\u20134.","journal-title":"J Perinatol"},{"key":"1242_CR17","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.jash.2016.10.005","volume":"10","author":"PD Levy","year":"2016","unstructured":"Levy PD, Willock RJ, Burla M, Brody A, Mahn J, Marinica A, et al. Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction. J Am Soc Hypertens. 2016;10:906\u201316.","journal-title":"J Am Soc Hypertens"},{"key":"1242_CR18","doi-asserted-by":"publisher","first-page":"997","DOI":"10.3390\/jcm12030997","volume":"12","author":"U Anceschi","year":"2023","unstructured":"Anceschi U, Mormando M, Flammia RS, Fiori C, Zappal\u00e0 O, Concilio BD, et al. The therapeutic intensity score as predictor of clinical outcomes after total and partial adrenalectomy for unilateral primary aldosteronism: results of a multicentric series. J Clin Med. 2023;12:997.","journal-title":"J Clin Med"},{"key":"1242_CR19","first-page":"31","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31\u201341.","journal-title":"Nephron"},{"key":"1242_CR20","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1001\/jama.289.5.579","volume":"289","author":"K Reynolds","year":"2003","unstructured":"Reynolds K, Lewis B, Nolen JDL, Kinney GL, Sathya B, He J. Alcohol consumption and risk of stroke: a meta-analysis. JAMA. 2003;289:579\u201388.","journal-title":"JAMA"},{"key":"1242_CR21","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","volume":"83","author":"J Staals","year":"2014","unstructured":"Staals J, Makin SDJ, Doubal FN, Dennis MS, Wardlaw JM. Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden. Neurology. 2014;83:1228\u201334.","journal-title":"Neurology"},{"key":"1242_CR22","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk J, Alavi A, Hurtig H, Zimmerman R. MR signal abnormalities at 1.5 T in alzheimer\u2019s dementia and normal aging. Am J Roentgenol. 1987;149:351\u20136.","journal-title":"Am J Roentgenol"},{"key":"1242_CR23","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","volume":"12","author":"JM Wardlaw","year":"2013","unstructured":"Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822\u201338.","journal-title":"Lancet Neurol"},{"key":"1242_CR24","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1136\/jnnp.2003.030858","volume":"75","author":"AMJ MacLullich","year":"2004","unstructured":"MacLullich AMJ, Wardlaw JM, Ferguson KJ, Starr JM, Seckl JR, Deary IJ. Enlarged perivascular spaces are associated with cognitive function in healthy elderly men. J Neurol, Neurosurg Psychiatry. 2004;75:1519\u201323.","journal-title":"J Neurol, Neurosurg Psychiatry"},{"key":"1242_CR25","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159:702\u20136.","journal-title":"Am J Epidemiol"},{"key":"1242_CR26","doi-asserted-by":"publisher","first-page":"e53","DOI":"10.1161\/HYP.0000000000000084","volume":"72","author":"RM Carey","year":"2018","unstructured":"Carey RM, Calhoun DA, Bakris GL, Brook RD, Daugherty SL, Dennison-Himmelfarb CR, et al. Resistant hypertension: detection, evaluation, and management: a scientific statement from the American Heart Association. Hypertension. 2018;72:e53\u2013e90.","journal-title":"Hypertension"},{"key":"1242_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1097\/CRD.0b013e318248a3e1","volume":"20","author":"CR Palmeiro","year":"2012","unstructured":"Palmeiro CR, Anand R, Dardi IK, Balasubramaniyam N, Schwarcz MD, Weiss IA. Growth hormone and the cardiovascular system. Cardiol Rev. 2012;20:197\u2013207.","journal-title":"Cardiol Rev"},{"key":"1242_CR28","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3390\/ijms19010290","volume":"19","author":"D Caicedo","year":"2018","unstructured":"Caicedo D, D\u00edaz O, Devesa P, Devesa J. Growth hormone (GH) and cardiovascular system. Int J Mol Sci. 2018;19:290.","journal-title":"Int J Mol Sci"},{"key":"1242_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.989064","volume":"13","author":"Q Qiu","year":"2022","unstructured":"Qiu Q, Song W, Zhou X, Yu Z, Wang M, Hao H, et al. Heart rate variability is associated with cerebral small vessel disease in patients with diabetes. Front Neurol. 2022;13:989064.","journal-title":"Front Neurol"},{"key":"1242_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11172-1","volume":"12","author":"LA Dobrynina","year":"2022","unstructured":"Dobrynina LA, Shamtieva KV, Kremneva EI, Zabitova MR, Akhmetzyanov BM, Gnedovskaya EV, et al. Daily blood pressure profile and blood\u2013brain barrier permeability in patients with cerebral small vessel disease. Sci Rep. 2022;12:7723.","journal-title":"Sci Rep"},{"key":"1242_CR31","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1007\/s00415-018-9077-3","volume":"266","author":"X Chen","year":"2019","unstructured":"Chen X, Wang J, Shan Y, Cai W, Liu S, Hu M, et al. Cerebral small vessel disease: neuroimaging markers and clinical implication. J Neurol. 2019;266:2347\u201362.","journal-title":"J Neurol"},{"key":"1242_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3109\/1354750X.2011.599074","volume":"16","author":"C Zweifel","year":"2011","unstructured":"Zweifel C, Katan M, Schuetz P, Ernst A, Mariani L, M\u00fcller B, et al. Growth hormone and outcome in patients with intracerebral hemorrhage: a pilot study. Biomarkers. 2011;16:511\u20136.","journal-title":"Biomarkers"}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01242-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01242-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T17:01:59Z","timestamp":1791910919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-026-01242-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,13]]},"references-count":32,"alternative-id":["1242"],"URL":"https:\/\/doi.org\/10.1038\/s41371-026-01242-6","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,13]]},"assertion":[{"value":"13 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Motohiro Okumura reports lecture fees from Daiichi Sankyo Co. Ltd. outside the submitted work. Takeo Sato reports lecture and travel fees from Pfizer Japan Inc. and Daiichi Sankyo Co. Ltd., and lecture fees from Kowa Co. Ltd. outside the submitted work. Yuki Tsujimoto reports no disclosures. Kenji Yamashiro reports subsidies from Teijin Pharma Ltd. and Ono Pharmaceutical Co. Ltd. outside the submitted work. Yui Watanabe reports no disclosures. Satoshi Matsushima reports no disclosures. Tetsuya Shimizu reports no disclosures. Taku Gomi reports no disclosures. Hideto Kuribayashi reports no disclosures. Teppei Komatsu reports no disclosures. Kenichi Sakuta reports no disclosures. Kenichiro Sakai reports no disclosures. Hidetaka Mitsumura reports no disclosures. Rimei Nishimura reports honoraria from Sanofi Co., Ltd., Medtronic Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., Takeda Pharmaceutical Co., Ltd., Kissei Pharmaceutical Co., Ltd., Novartis Pharma Co., Ltd., Eli Lilly Japan Co., Ltd., Novo Nordisk Pharma Co., Ltd., MSD, Astellas Pharma Inc., and Abbot; as well as subsidies and donations from Taisho Pharmaceutical Co., Ltd., Ono Pharmaceutical Co., Ltd., Takeda Pharmaceutical Co., Ltd., Nippon Boehringer Ingelheim Co., Ltd., and Abbott outside the submitted work. Yasuyuki Iguchi reports speaker honoraria from AbbVie, Alexion, Amgen, Biogen, Bristol Myers Squibb, Chugai, CSL-Behring, Daiichi-Sankyo, Eisai, Fujimoto Pharma, JB, Mitsubishi-Tanabe, Novartis, Otsuka, Pfizer, Sumitomo Pharma, and Takeda; and research support from Boehringer Ingelheim, Fujimoto Pharma, Chugai, Japan Blood Products Organization, Daiichi-Sankyo, Mitsubishi-Tanabe, Medical Concierge Co., Ltd., NAGATANIEN Co., Ltd., Shionogi, and Otsuka outside the submitted work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors used ChatGPT during preparation of this work to improve readability and language. After using this tool, the authors reviewed and edited the content as needed and take full responsibility for the content of the publication.","order":2,"name":"Ethics","label":"Declaration of Generative AI and AI-assisted technologies in the writing process","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by the Regional Ethics and Hospital Management Committee of the Jikei University School of Medicine (approval number: 31-256 [9755]) and was conducted in accordance with the guidelines of this ethics committee and the Declaration of Helsinki. We also used data from the Jikei Stroke Registry, which was approved by the Regional Ethics and Hospital Management Committee of the Jikei University School of Medicine (approval numbers: 29-195 [8811], 29-196 [8812], and 29-197 [8813]). Written informed consent was obtained from all included patients.","order":3,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}